Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/120520

Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model
Laquente, Berta; Lacasa Salavert, Cristina; Ginestà, Mireia M.; Casanovas i Casanovas, Oriol; Figueras i Amat, Agnès; Galán, Maica; García Ribas, Ignacio; Germà Lluch, José Ramón; Capellá, G. (Gabriel); Viñals Canals, Francesc
Gemcitabine shows a marked antitumor effect as a result of its cytotoxic action toward proliferative cells. In this article, we aim to investigate the potential antitumor and antiangiogenic effect of gemcitabine following a metronomic schedule that involves the regular administration of cytotoxic drugs at doses lower than standard treatment. In vitro results showed that human endothelial cells are more sensitive to gemcitabine (IC50 3 nmol/L) than pancreatic tumor cells (IC50 20 nmol/L). For in vivo studies, we used an orthotopic implantation model of human pancreatic carcinoma in nude mice. Gemcitabine was administered i.p. following a low-dose schedule (1 mg/kg/d for a month) and compared with the conventional schedule (100 mg/kg days 0, 3, 6, and 9 postimplantation). Metronomic treatment effect on established tumor was equivalent to standard administration. The measure of CD31 endothelial marked area allowed us to show an in vivo antiangiogenic effect of this drug that was further enhanced by using metronomic administration. This effect correlated with an induction of thrombospondin-1, a natural inhibitor of angiogenesis. Our results allow us to hypothesize that, in addition to a direct antiproliferative or cytotoxic antiendothelial cell effect, a secondary effect involving thrombospondin-1 induction might provide an explanation for the specificity of the effects of metronomic gemcitabine treatment.
-Medicaments antineoplàstics
-Quimioteràpia del càncer
-Càncer de pàncrees
-Angiogènesi
-Antineoplastic agents
-Cancer chemotherapy
-Pancreas cancer
-Neovascularization
(c) American Association for Cancer Research, 2008
Artículo
Artículo - Versión aceptada
American Association for Cancer Research
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Vives, Marta; Ginestà, Mireia M.; Gracova, Kristina; Graupera i Garcia-Milà, Mariona; Casanovas i Casanovas, Oriol; Capellá, G. (Gabriel); Serrano Piñol, M. Teresa; Laquente, Berta; Viñals Canals, Francesc
Del Valle-Pérez, Beatriz; Martínez, Vanesa Gabriela; Lacasa Salavert, Cristina; Figueras i Amat, Agnès; Shapiro, Sandor S.; Takafuta, Toshiro; Casanovas i Casanovas, Oriol; Capellá, G. (Gabriel); Ventura Pujol, Francesc; Viñals Canals, Francesc
Figueras i Amat, Agnès; Arbós i Via, Maria Antònia; Quiles, Maria Teresa; Viñals Canals, Francesc; Germà Lluch, José Ramón; Capellá, G. (Gabriel)
Figueras i Amat, Agnès; Arbós i Via, Maria Antònia; Quiles, Maria Teresa; Viñals Canals, Francesc; Germà Lluch, José Ramón; Capellá, G. (Gabriel)
Castillo-Ávila, Wilmar; Piulats, Josep M.; García del Muro Solans, Xavier; Vidal-Bel, August; Condom i Mundó, Enric; Casanovas i Casanovas, Oriol; Mora, Josefina; Germà Lluch, José Ramón; Capellá, G. (Gabriel); Villanueva Garatachea, Alberto; Viñals Canals, Francesc